CHICAGO----NeuroTherapeutics Pharma, Inc., or NTP, a biopharmaceutical company focused on developing novel therapies for central nervous system disorders, today announced that it received a $100,000 investment from the Epilepsy Therapy Project.

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News